Loading…

Area under the curve and ratio difference spectrophotometric methods with evaluation of the greenness for simultaneous determination of olmesartan medoxomil and metoprolol succinate

•New methods were developed for simultaneous determination of olmesartan medoxomil and metoprolol succinate.•Area under the curve and ratio difference spectrophotometric methods were used.•The developed methods are simple, accurate and co-friendly with excellent greenness on Eco-scale.•The developed...

Full description

Saved in:
Bibliographic Details
Published in:Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Molecular and biomolecular spectroscopy, 2023-12, Vol.303, p.123164, Article 123164
Main Authors: Kamel, Doaa N., Hammad, Sherin F., Kamal, Amira H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•New methods were developed for simultaneous determination of olmesartan medoxomil and metoprolol succinate.•Area under the curve and ratio difference spectrophotometric methods were used.•The developed methods are simple, accurate and co-friendly with excellent greenness on Eco-scale.•The developed methods are economic and time saving. The aim of this study is to develop and validate two simple spectrophotometric methods for simultaneous determination of metoprolol succinate (MET) and olmesartan medoxomil (OLM) in tablet form. Method (I) was area under the curve (AUC) method. This approach involved the measuring of the area over a variety of wavelengths. Two wavelength ranges; 213–230 nm and 244–266 nm were chosen for determination of MET and OLM, respectively. Method (II) was ratio difference spectrophotometricmethod. For determination of MET, the ratio spectra were generated using 15 μg/mL OLM as a divisor then the peak to trough amplitudes between 221 nm and 245 nm were displayed versus the corresponding concentrations of MET. For determination of OLM, the peak-to-peak amplitudes between 247 and 293 nm were chosen and found to be directly proportional to OLM concentrations using 15 μg/mL MET as a divisor. The linearity ranges were 2–30 μg/mL and 2–25 μg/mL for MET and OLM, respectively. The assay results showed good mean %recovery ± SD as well as good agreement with that of the reported method. The developed methods were validated according to ICH guidelines. The developed methods are accurate, precise, eco-friendly and could be applied successfully to estimate OLM and MET in their combined dosage form.
ISSN:1386-1425
DOI:10.1016/j.saa.2023.123164